Yoshito Takeda

5.3k total citations
113 papers, 2.0k citations indexed

About

Yoshito Takeda is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Yoshito Takeda has authored 113 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pulmonary and Respiratory Medicine, 39 papers in Oncology and 24 papers in Molecular Biology. Recurrent topics in Yoshito Takeda's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers), Lung Cancer Research Studies (15 papers) and Lung Cancer Treatments and Mutations (13 papers). Yoshito Takeda is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers), Lung Cancer Research Studies (15 papers) and Lung Cancer Treatments and Mutations (13 papers). Yoshito Takeda collaborates with scholars based in Japan, United States and United Kingdom. Yoshito Takeda's co-authors include Takashi Kijima, Isao Tachibana, Atsushi Kumanogoh, Ichiro Kawase, Hiroshi Kida, Izumi Nagatomo, Toru Kumagai, Haruhiko Hirata, Tadashi Osaki and Mitsuhiro Yoshida and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Yoshito Takeda

104 papers receiving 2.0k citations

Peers

Countries citing papers authored by Yoshito Takeda

Since Specialization

Citations

This map shows the geographic impact of Yoshito Takeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshito Takeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshito Takeda more than expected).

Fields of papers citing papers by Yoshito Takeda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshito Takeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshito Takeda. The network helps show where Yoshito Takeda may publish in the future.

Co-authorship network of co-authors of Yoshito Takeda

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshito Takeda. A scholar is included among the top collaborators of Yoshito Takeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshito Takeda. Yoshito Takeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Balloon Dilatation for Bronchoscope Delivery: First-in-Human Trial of a Novel Technique for Ultra-peripheral Lung Field Access 2025 ·American Journal of Respiratory and Critical Care Medicine ·Kotaro Miyake, Masahide Oki, Hidekazu Suzuki, (unknown), Shinji Sasada, (unknown), Tatsuya Imabayashi, Yoshihito Kogure, Takayuki Shiroyama, Haruhiko Hirata, Izumi Nagatomo, Yoshito Takeda, Atsushi Kumanogoh	0
2	Real‐World Efficacy and Safety of Lenvatinib in Advanced or Recurrent Thymic Carcinoma: A Multicenter Retrospective Study in Japan 2025 ·Thoracic Cancer ·Shimpei Miyamoto, (unknown), Hanako Kuhara, (unknown), Takayuki Shiroyama, Motohiro Tamiya, Akihiro Tamiya, Kazumi Nishino, Yoshito Takeda, Takashi Kijima, Meinoshin Okumura, Atsushi Kumanogoh, Masahide Mori	1
3	Timing of first pembrolizumab infusion and long-term outcomes in non-small cell lung cancer: A retrospective multicenter study 2025 ·European Journal of Cancer ·(unknown), Kinnosuke Matsumoto, Akihiro Tamiya, Motohiro Tamiya, Masahide Mori, Hidekazu Suzuki, Takayuki Shiroyama, (unknown), (unknown), (unknown), (unknown), (unknown), Tomoki Kuge, Yuhei Kinehara, Koji Azuma, (unknown), (unknown), Yoshito Takeda, Atsushi Kumanogoh	0
4	Tetracyclines enhance antitumor T-cell immunity via the Zap70 signaling pathway 2024 ·Journal for ImmunoTherapy of Cancer ·Mari Tone, Kota Iwahori, Michinari Hirata, Azumi Ueyama, Akiyoshi Tani, Jun‐ichi Haruta, Yoshito Takeda, Yasushi Shintani, Atsushi Kumanogoh, Hisashi Wada	6
5	Cancer-associated SNRPD3 mutation confers resistance to hypoxia, which is attenuated by DRP1 inhibition 2024 ·Biochemical and Biophysical Research Communications ·S. Satoh, Kotaro Miyake, Yuichi Adachi, Kentaro Masuhiro, (unknown), Yujiro Naito, Takayuki Shiroyama, Shohei Koyama, Yuta Yamaguchi, (unknown), Hyota Takamatsu, Daisuke Okuzaki, Izumi Nagatomo, Yoshito Takeda, Atsushi Kumanogoh	1
6	MicroRNA-130a-3p regulates osimertinib resistance by targeting runt-related transcription factor 3 in lung adenocarcinoma 2024 ·Scientific Reports ·Takuya Shintani, (unknown), (unknown), Kenji Ikemura, Takayuki Shiroyama, Izumi Nagatomo, Kentaro Jingushi, Yoshito Takeda, Atsushi Kumanogoh, Masahiro Okuda	0
7	Risk Stratification According to Baseline and Early Change in Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Treated with Chemoimmunotherapy: A Multicenter Real-World Study 2024 ·Targeted Oncology ·Kinnosuke Matsumoto, Yuji Yamamoto, Takayuki Shiroyama, Tomoki Kuge, Masahide Mori, Motohiro Tamiya, Yuhei Kinehara, Akihiro Tamiya, Hidekazu Suzuki, (unknown), Kiyonobu Ueno, (unknown), Izumi Nagatomo, Yoshito Takeda, Atsushi Kumanogoh	0
8	Idiopathic pulmonary fibrosis-specific Bayesian network integrating extracellular vesicle proteome and clinical information 2024 ·Scientific Reports ·(unknown), Yohei Mineharu, (unknown), Yoshinori Tamada, M Itoh, Masataka Kuroda, Jun Adachi, Yoshito Takeda, Kenji Mizuguchi, Atsushi Kumanogoh, Yayoi Natsume‐Kitatani, Yasushi Okuno	4
9	Variability in non-tumor areas of colorectal cancer patients as revealed by endoscopic intestinal step biopsies 2024 ·Molecular Cancer ·Shoko Ikuta, Yutaka Saito, (unknown), Yoichiro Nakatani, Izumi Nagatomo, Satoshi Shiba, Yoshito Takeda, Yasushi Totoki, Sayaka Mizutani, Hironori Sunakawa, Hiroaki Ikematsu, Hiroyuki Takamaru, Atsushi Kumanogoh, Shinichi Yachida	1
10	A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients 2023 ·Proceedings of the National Academy of Sciences ·Jonas Nørskov Søndergaard, (unknown), Ryuya Edahiro, Yuya Shirai, Yuta Yamaguchi, Teruaki Murakami, Takayoshi Morita, Yasuhiro Kato, Haruhiko Hirata, Yoshito Takeda, Daisuke Okuzaki, Shimon Sakaguchi, Atsushi Kumanogoh, Yukinori Okada, James B. Wing	10
11	Virtual fluoroscopic preprocedural planning using Ziostation2 for transbronchial biopsy: A prospective self-controlled study 2023 ·Respiratory Investigation ·Yuko Abe, Kotaro Miyake, Takayuki Shiroyama, Haruhiko Hirata, Izumi Nagatomo, Yoshito Takeda, Atsushi Kumanogoh	1
12	A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19 2023 ·Scientific Reports ·Kota Iwahori, Takuro Nii, (unknown), Takahiro Kawasaki, (unknown), Kazuki Hashimoto, Takanori Matsuki, Kazuyuki Tsujino, Keisuke Miki, Akio Osa, Sho Goya, (unknown), Masahide Mori, Yoshito Takeda, Tomomi Yamada, Hiroshi Kida, Atsushi Kumanogoh	1
13	Association of the RPA3-UMAD1 locus with interstitial lung diseases complicated with rheumatoid arthritis in Japanese 2020 ·Annals of the Rheumatic Diseases ·Yuya Shirai, Suguru Honda, Katsunori Ikari, Masahiro Kanai, Yoshito Takeda, Yoichiro Kamatani, Takayuki Morisaki, Eiichi Tanaka, Atsushi Kumanogoh, Masayoshi Harigai, Yukinori Okada	28
14	Preventive Role of Tetraspanin CD9 in Systemic Inflammation of Chronic Obstructive Pulmonary Disease 2015 ·American Journal of Respiratory Cell and Molecular Biology ·Yoshito Takeda, Mayumi Suzuki, Yingji Jin, Isao Tachibana	9
15	HER2 As Therapeutic Target for Overcoming ATP-Binding Cassette Transporter–Mediated Chemoresistance in Small Cell Lung Cancer 2012 ·Molecular Cancer Therapeutics ·Toshiyuki Minami, Takashi Kijima, Yasushi Otani, (unknown), Ryo Takahashi, Izumi Nagatomo, Haruhiko Hirata, Mayumi Suzuki, Koji Inoue, Yoshito Takeda, Hiroshi Kida, Isao Tachibana, Atsushi Kumanogoh	24
16	Diminished metastasis in tetraspanin CD151–knockout mice 2011 ·Blood ·Yoshito Takeda, Qinglin Li, Alexander R. Kazarov, Mathieu Epardaud, Kutlu G. Elpek, Shannon J. Turley, Martin E. Hemler	42
17	Early [18F]Fluorodeoxyglucose Positron Emission Tomography at Two Days of Gefitinib Treatment Predicts Clinical Outcome in Patients with Adenocarcinoma of the Lung 2011 ·Clinical Cancer Research ·Ryo Takahashi, Haruhiko Hirata, Isao Tachibana, Eku Shimosegawa, Atsuo Inoue, Izumi Nagatomo, Yoshito Takeda, Hiroshi Kida, Sho Goya, Takashi Kijima, Mitsuhiro Yoshida, Toru Kumagai, Atsushi Kumanogoh, Meinoshin Okumura, Jun Hatazawa, Ichiro Kawase	78
18	Two cases of leptomeningeal metastases from lung adenocarcinoma which progressed during gefitinib therapy but responded to erlotinib 2011 ·International Journal of Clinical Oncology ·Satoshi Tetsumoto, Akio Osa, Takashi Kijima, Toshiyuki Minami, Haruhiko Hirata, Ryo Takahashi, Hanako Kuhara, Izumi Nagatomo, Yoshito Takeda, Hiroshi Kida, Sho Goya, Isao Tachibana, Ichiro Kawase	14
19	Involvement of Endothelial Apoptosis Underlying Chronic Obstructive Pulmonary Disease–like Phenotype in Adiponectin-null Mice: Implications for Therapy 2011 ·American Journal of Respiratory and Critical Care Medicine ·Kaori Nakanishi, Yoshito Takeda, Satoshi Tetsumoto, Takeo Iwasaki, Kazuyuki Tsujino, Hanako Kuhara, Yingji Jin, Izumi Nagatomo, Hiroshi Kida, (unknown), Takashi Kijima, Norikazu Maeda, Tohru Funahashi, Iichiro Shimomura, Isao Tachibana, Ichiro Kawase	57
20	Tetraspanin CD9 Negatively Regulates Lipopolysaccharide-Induced Macrophage Activation and Lung Inflammation 2009 ·The Journal of Immunology ·Mayumi Suzuki, Isao Tachibana, Yoshito Takeda, Ping He, Seigo Minami, Takeo Iwasaki, Hiroshi Kida, (unknown), Takashi Kijima, Mitsuhiro Yoshida, Toru Kumagai, Tadashi Osaki, Ichiro Kawase	70

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact